✅ Key Benefits

• Dual-action formulation: Combines Atorvastatin, an HMG-CoA reductase inhibitor, with Ezetimibe, a cholesterol absorption inhibitor, to provide a comprehensive approach to lowering cholesterol levels.

• Effective lipid management: Reduces LDL-C, total cholesterol, and triglycerides while increasing HDL-C, thereby improving overall lipid profile.

• Indications:

  • Primary hyperlipidemia

  • Mixed dyslipidemia

  • Homozygous and heterozygous familial hypercholesterolemia

  • Cardiovascular risk reduction in high-risk patients

• Convenient dosing: Typically administered once daily, with or without food, enhancing patient adherence to therapy.